DGAP-News: Alphaform AG / Key word(s): Preliminary Results Alphaform AG: Preliminary figures 2014 - Alphaform targets double-digit revenue growth in 2015 26.02.2015 / 17:19 --------------------------------------------------------------------- Press release Preliminary figures 2014 - Alphaform targets double-digit revenue growth in 2015 - Preliminary figures 2014: revenue increases to Euro 29 million, consolidated net result improves to Euro -3.2 million - Alphaform Excellence programme now in effect at all locations Feldkirchen, 26. February 2015. According to preliminary calculations, Alphaform AG, Europe's leading 3D printing service provider, increased its revenue by 11.6 percent to Euro 29 million in 2014. The growth was primarily based on positive performance in the two business segments Additive Manufacturing Metal and Rapid Tooling and Precision Casting at the Eschenlohe and Stade sites. As planned, the Alphaform Excellence programme launched in early 2014 took full effect here. Alphaform is ensuring its success in the third business segment, Additive Manufacturing Plastic at the Feldkirchen site, with an 11-point plan issued in October 2014. The remaining process and structural defects impeded the attainment of the Euro 30 million mark originally intended for 2014. As expected, the implementation of the 11-point plan necessitated additional expenses in the fourth quarter of 2014; the costs for external consultants alone totalled approximately Euro 1 million in the last financial year. After winning the biggest order in the company's history amounting to Euro 10 million at the end of 2014, there were also already considerable expenses for production preparations. According to preliminary calculations, EBITDA subsequently reached Euro -1.4 million in 2014, but this was significantly higher than the previous year's figure of Euro -3.5 million. The consolidated net result also improved to Euro -3.2 million according to preliminary calculations after Euro -6.2 million in the previous year. The difficult economic situation in the Formula 1 industry, which had been an important customer in prototyping, particularly in the early years, prevented a further reduction of the loss. In the fourth quarter of 2014, Alphaform wrote off receivables against two racing teams of Euro 0.2 million. Conclusion of the Alphaform Excellence programme in 2015 With the Excellence programme, Alphaform optimised structures and processes and strengthened sales and the corporate culture in the last financial year, thus laying the necessary foundations for the transition from a manufacturing and prototyping operation to industrial production. In the course of 2015, Alphaform will conclude this programme and the associated 11-point plan. For 2015 as a whole, Alphaform then expects double-digit revenue growth. Over the course of the year, the company is also likely to exceed the break-even point in terms of operating cash flow. "2014 was heavily influenced by extensive restructuring," explains Alphaform CEO Dr Hanns-Dieter Aberle, "now the focus is quite clearly on a consistent implementation of our growth strategy." The company may have to continue shouldering considerable expenses for the expansion, but it benefited from tailwind in the 3D market, a robust business model and a high degree of production industrialisation compared to the rest of the sector. About Alphaform Founded in 1996 and headquartered in Feldkirchen near Munich, Alphaform AG is a leading European handler for the renovation of industrial development and production with innovative 3D printing and rapid technologies. As a service provider, Alphaform guides its clients from product development through to product manufacture; it assists them in introducing and utilising innovations and delivers expertise, engineering knowledge, prototypes, individual parts, small-scale series, series and project management. Among others, Alphaform today serves the premium manufacturers of the automotive industry, mechanical, plant and automotive engineering, the aerospace industry, tool making and medical technology. Its particular areas of expertise include complex assembly, lightweight construction and orthopaedic implants and instruments. It has subsidiaries in Germany, Finland, Sweden and the UK. Alphaform's shares are listed in the Prime Standard segment of the Frankfurt stock exchange (code: ATF; securities code number (WKN): 548 795). Contact: Dr. Hanns-Dieter Aberle, CEO Thomas Kresser, CFO ALPHAFORM AG ALPHAFORM AG Kapellenstraße 10 Kapellenstraße 10 85622 Feldkirchen 85622 Feldkirchen Tel.: +49 89 905002 35 Tel.: +49 89 905002 35 Fax: +49 89 905002 1035 Fax: +49 89 905002 1035 e-mail: [email protected] e-mail: [email protected] Internet: www.alphaform.de Internet: www.alphaform.de Disclaimer This press release/ad-hoc disclosure is not an offer document and does not constitute an offer of shares of Alphaform AG ("Company") nor an invitation to an offer to buy or subscribe for shares or securities of the Company but is provided for information only. This press release/ad-hoc disclosure may contain forward-looking statements that are subject to risks and uncertainties, including those pertaining to the anticipated benefits to be realized from the proposals described herein. Forward-looking statements may include, in particular, statements about future events, future financial performance, plans, strategies, expectations, prospects, competitive environment, regulation and supply and demand. The Company has based these forward-looking statements on its views and assumptions with respect to future events and financial performance. Actual financial performance could differ materially from that projected in the forward-looking statements due to the inherent uncertainty of estimates, forecasts and projections, and financial performance may be better or worse than anticipated. Given these uncertainties, persons should not put undue reliance on any forward-looking statements. The information contained in this presentation is subject to change without notice and the Company does not undertake any duty to update the forward-looking statements, and the estimates and assumptions associated with them, except to the extent required by applicable laws and regulations. Important notice to persons in the United States of America All information in this press release/ad-hoc disclosure is being made available in the United States of America only to persons believed by the Company to be capable of understanding and evaluating the risks of a transaction. No shares or other securities of the Company have been registered or otherwise qualify for a public sale or resale under federal or state laws in the United States of America. Each recipient of information doing business in or organized under any federal or state laws in the United States of America or in areas subject to its jurisdiction represents that it is an "accredited investor" as defined by Rule 501 or Regulation D under the Securities Act of 1993 ("the Act") and acknowledges that none of the shares in the Company will be registered under the Act and cannot be resold in the absence of such registration or the availability of an exemption there from. The shares in the Company have not been approved or disapproved by the United States Securities and Exchange Commission, any state securities commission or other regulatory authority, nor have any of these authorities passed judgment upon or endorsed the merits of an investment in the shares of the Company or the accuracy or adequacy of this presentation. Any representation to the contrary is a criminal offence. Important notice to persons in the United Kingdom All information in this press release/ad-hoc disclosure is being made available to the recipients on the basis that they are persons covered by Article 11(3) of the Financial Services Act 1986 (Investment Advertisements) (Exemptions) Order 1996. By accepting this document the recipient warrants and represents that he or it is such a person. --------------------------------------------------------------------- 26.02.2015 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Alphaform AG Kapellenstraße 10 85622 Feldkirchen Germany Phone: +49 (0)89 905002 - 0 Fax: +49 (0)89 905002 - 90 E-mail: [email protected] Internet: www.alphaform.de ISIN: DE0005487953 WKN: 548795 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 327507 26.02.2015